Last month, Germany announced that the nation’s legal medical cannabis import sector had reached its limit of 122 tonnes of medical cannabis products. Germany’s emerging medical cannabis market has served as the top international destination for legal products exported from other countries. Thankfully, the limit has been reportedly increased, paving the way for more imports.

“The Federal Institute for Drugs and Medical Devices (BfArM) has increased the maximum quantity of cannabis imports for medical and scientific purposes to approximately 192.5 tons.” reported krautinvest in its local coverage (translated from German to English).

“The BfArM had not approved any imports since mid-September, as the original limit of 122 tons had been exhausted. As the BfArM informed krautinvest, it has already approved cannabis imports again since the beginning of this week.” the outlet also reported.

Medical cannabis imports have increased quarter over quarter in recent years in Germany. In the second quarter of 2025 alone, Germany imported 43.257 tonnes of medical cannabis products according to BfArM’s data.

That is an increase over the previous record set in Q1 2025 of 37.519 tonnes, and a significant increase compared to Q2 2024, when Germany imported 11.634 tonnes of medical cannabis products. Below is a graph of import data from BfArM:

Canada has served as the top source of medical cannabis imports to Germany, with BfArM reporting that Germany imported 36.164 tonnes of medical cannabis products from Canada in the first half of 2025. By comparison, 25.524 tonnes have been imported to Germany from Portugal in the first half of 2025.

Below is a breakdown of countries of origin for medical cannabis imports to Germany in 2024 and the first half of 2025, via BfArM:

Despite the success of Germany’s medical cannabis industry, cannabis opponents in Germany’s government continue to push for regressive medical cannabis policies and regulations. Earlier this month, Germany’s Federal Cabinet approved a measure that would amend the Medical Cannabis Act (MedCanG).

The measure was drafted by the Federal Ministry of Health (BMG), and per a government press release, includes the following changes (translated from German to English):

• In the future, medical cannabis can only be prescribed after personal contact between the patient and the doctor, either in the doctor’s office or during a home visit. This requires consideration of the patient’s health status, individual illnesses, and other medications being used, which generally requires a careful medical history and physical examination. Furthermore, ongoing information about the risk of addiction and possible physical or psychological consequences of consumption, which can change depending on the extent and duration of consumption, is required.
• For follow-up prescriptions, a face-to-face consultation is required every four quarters, with the previous contact within that period being related to the prescription of cannabis for medical purposes. Under this condition, a prescription may also be made via telemedicine in the following three quarters.
• The mail-order option for medicinal cannabis is excluded, as there are comprehensive information and consultation obligations that must be provided during a personal consultation at the pharmacy. Pharmacies’ delivery services remain unaffected.

The German Hemp Association (DHV) has launched a nationwide email campaign in opposition to the Cabinet’s recent approval.

“Nina Warken’s bill, banning telemedical prescriptions and the shipping of cannabis flowers, seems like a poorly intended joke for a coalition that came to power on the promise of greater efficiency and digitalization. The law, in its current form, would lead to a massive deterioration in the care of patients who urgently need low-threshold access to cannabis as medicine, primarily affecting the most vulnerable among them.” stated DHV in a press release about their email campaign (translated from German to English).

“Therefore, we are addressing an email campaign to all CDU/CSU members of the Bundestag. With just a few clicks, you can email your local representative and request that they make extensive adjustments to the current draft bill during the parliamentary process. Please help and do your part to ensure that low-threshold access to medicinal cannabis will continue to be available throughout Germany in the future.” DHV also stated. Medical cannabis supporters in Germany are urged to support DHV’s campaign.